394 related articles for article (PubMed ID: 16642000)
1. Targeting C-reactive protein for the treatment of cardiovascular disease.
Pepys MB; Hirschfield GM; Tennent GA; Gallimore JR; Kahan MC; Bellotti V; Hawkins PN; Myers RM; Smith MD; Polara A; Cobb AJ; Ley SV; Aquilina JA; Robinson CV; Sharif I; Gray GA; Sabin CA; Jenvey MC; Kolstoe SE; Thompson D; Wood SP
Nature; 2006 Apr; 440(7088):1217-21. PubMed ID: 16642000
[TBL] [Abstract][Full Text] [Related]
2. Limiting myocardial damage during acute myocardial infarction by inhibiting C-reactive protein.
Kitsis RN; Jialal I
N Engl J Med; 2006 Aug; 355(5):513-5. PubMed ID: 16885557
[No Abstract] [Full Text] [Related]
3. Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy.
Thiele JR; Habersberger J; Braig D; Schmidt Y; Goerendt K; Maurer V; Bannasch H; Scheichl A; Woollard KJ; von Dobschütz E; Kolodgie F; Virmani R; Stark GB; Peter K; Eisenhardt SU
Circulation; 2014 Jul; 130(1):35-50. PubMed ID: 24982116
[TBL] [Abstract][Full Text] [Related]
4. Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites.
Braig D; Nero TL; Koch HG; Kaiser B; Wang X; Thiele JR; Morton CJ; Zeller J; Kiefer J; Potempa LA; Mellett NA; Miles LA; Du XJ; Meikle PJ; Huber-Lang M; Stark GB; Parker MW; Peter K; Eisenhardt SU
Nat Commun; 2017 Jan; 8():14188. PubMed ID: 28112148
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction.
Griselli M; Herbert J; Hutchinson WL; Taylor KM; Sohail M; Krausz T; Pepys MB
J Exp Med; 1999 Dec; 190(12):1733-40. PubMed ID: 10601349
[TBL] [Abstract][Full Text] [Related]
6. Chemical knockout of C-reactive protein in cardiovascular disease.
Heinecke JW
Nat Chem Biol; 2006 Jun; 2(6):300-1. PubMed ID: 16710337
[No Abstract] [Full Text] [Related]
7. Recognition functions of pentameric C-reactive protein in cardiovascular disease.
Agrawal A; Gang TB; Rusiñol AE
Mediators Inflamm; 2014; 2014():319215. PubMed ID: 24948846
[TBL] [Abstract][Full Text] [Related]
8. Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats.
Gill R; Kemp JA; Sabin C; Pepys MB
J Cereb Blood Flow Metab; 2004 Nov; 24(11):1214-8. PubMed ID: 15545914
[TBL] [Abstract][Full Text] [Related]
9. C-Reactive Protein Mediating Immunopathological Lesions: A Potential Treatment Option for Severe Influenza A Diseases.
Gao R; Wang L; Bai T; Zhang Y; Bo H; Shu Y
EBioMedicine; 2017 Aug; 22():133-142. PubMed ID: 28734805
[TBL] [Abstract][Full Text] [Related]
10. Targeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational Changes.
Thiele JR; Zeller J; Bannasch H; Stark GB; Peter K; Eisenhardt SU
Mediators Inflamm; 2015; 2015():372432. PubMed ID: 26089599
[TBL] [Abstract][Full Text] [Related]
11. The physiological structure of human C-reactive protein and its complex with phosphocholine.
Thompson D; Pepys MB; Wood SP
Structure; 1999 Feb; 7(2):169-77. PubMed ID: 10368284
[TBL] [Abstract][Full Text] [Related]
12. Monomeric C-reactive protein modulates classic complement activation on necrotic cells.
Mihlan M; Blom AM; Kupreishvili K; Lauer N; Stelzner K; Bergström F; Niessen HW; Zipfel PF
FASEB J; 2011 Dec; 25(12):4198-210. PubMed ID: 21856781
[TBL] [Abstract][Full Text] [Related]
13. Possible mechanisms of C-reactive protein mediated acute myocardial infarction.
Fordjour PA; Wang Y; Shi Y; Agyemang K; Akinyi M; Zhang Q; Fan G
Eur J Pharmacol; 2015 Aug; 760():72-80. PubMed ID: 25895642
[TBL] [Abstract][Full Text] [Related]
14. Lectin-like oxidized LDL receptor 1 is involved in CRP-mediated complement activation.
Fujita Y; Yamaguchi S; Kakino A; Iwamoto S; Yoshimoto R; Sawamura T
Clin Chem; 2011 Oct; 57(10):1398-405. PubMed ID: 21821723
[TBL] [Abstract][Full Text] [Related]
15. Structure-Function Relationships of C-Reactive Protein in Bacterial Infection.
Ngwa DN; Agrawal A
Front Immunol; 2019; 10():166. PubMed ID: 30863393
[TBL] [Abstract][Full Text] [Related]
16. A Conformational Change in C-Reactive Protein Enhances Leukocyte Recruitment and Reactive Oxygen Species Generation in Ischemia/Reperfusion Injury.
Thiele JR; Zeller J; Kiefer J; Braig D; Kreuzaler S; Lenz Y; Potempa LA; Grahammer F; Huber TB; Huber-Lang M; Bannasch H; Stark GB; Peter K; Eisenhardt SU
Front Immunol; 2018; 9():675. PubMed ID: 29713320
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of sPLA2-IIA, C-reactive protein or complement: new therapy for patients with acute myocardial infarction?
Krijnen PA; Meischl C; Nijmeijer R; Visser CA; Hack CE; Niessen HW
Cardiovasc Hematol Disord Drug Targets; 2006 Jun; 6(2):113-23. PubMed ID: 16787196
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein in acute and delayed preconditioning of the rat heart.
Valtchanova-Matchouganska A; Gondwe M; Nadar A
Cardiovasc J S Afr; 2005; 16(2):118-23. PubMed ID: 15915280
[TBL] [Abstract][Full Text] [Related]
19. Protein-directed immobilization of phosphocholine ligands on a gold surface for multivalent C-reactive protein binding.
Kim E; Lee SG; Kim HC; Lee SJ; Baek CS; Jeong SW
Curr Top Med Chem; 2013; 13(4):519-24. PubMed ID: 23432014
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting C-reactive protein for the treatment of cardiovascular disease: promising evidence from rodent models.
Szalai AJ; McCrory MA; Xing D; Hage FG; Miller A; Oparil S; Chen YF; Mazzone M; Early R; Henry SP; Zanardi TA; Graham MJ; Crooke RM
Mediators Inflamm; 2014; 2014():353614. PubMed ID: 24803739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
